Free thyroxine, free triiodothyronine and thyroid-stimulating hormone before and after hemodialysis in Saudi patients with end-stage renal disease: Is there any difference?

by Khalid Alsaran, Alaa Sabry, Hosamuddin Alshahhat, Enas Babgy, Fatemah Alzahrani
Published 2011-01-01

Experience with second line drugs in frequently relapsing and steroid dependent childhood nephrotic syndrome in a large Saudi center

by Khalid Alsaran, M.D., Khalid Mirza, M.D., Abdulhadi Al-Talhi, M.D., Esam Al-Kanani
Published 2017-06-01